Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingre Huoxue Therapy for Rheumatoid Arthritis
NCT02551575Phase 3Unknown
- Sponsor
- Guang'anmen Hospital
- Start
- Nov 2014
- Primary completion
- Jun 2017
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) (3 arms), sponsored by Guang'anmen Hospital. Primary endpoint: Disease Activity Score 28 at 24 weeks. Status: unknown.
02
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02551575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02551575.